Abstract:Cancer immunotherapy has achieved remarkable success over the past decade by modulating patients' own immune systems and unleashing pre-existing immunity. However, only a minority of cancer patients across different cancer types are able to benefit from immunotherapy treatment; moreover, among those small portions of patients with response, intrinsic and acquired resistance remains a persistent challenge. Because the tumor microenvironment (TME) is well recognized to play a critical role in tumor initiation, progression, metastasis, and the suppression of the immune system and responses to immunotherapy, understanding the interactions between the TME and the immune system is a pivotal step in developing novel and efficient cancer immunotherapies. With unique features such as low reagent consumption, dynamic and precise fluid control, versatile structures and function designs, and 3D cell co-culture, microfluidic tumor organoid-on-a-chip platforms that recapitulate key factors of the TME and the immune contexture have emerged as innovative reliable tools to investigate how tumors regulate their TME to counteract antitumor immunity and the mechanism of tumor resistance to immunotherapy. In this comprehensive review, we focus on recent advances in tumor organoid-on-a-chip platforms for studying the interaction between the TME and the immune system. We first review different factors of the TME that recent microfluidic in vitro systems reproduce to generate advanced tools to imitate the crosstalk between the TME and the immune system. Then, we discuss their applications in the assessment of different immunotherapies' efficacy using tumor organoid-on-a-chip platforms. Finally, we present an overview and the outlook of engineered microfluidic platforms in investigating the interactions between cancer and immune systems, and the adoption of patient-on-a-chip models in clinical applications toward personalized immunotherapy.

Microfluidics guided by deep learning for cancer immunotherapy screening

Profiling of Immune-Cancer Interactions at the Single-Cell Level Using a Microfluidic Well Array.

ImmunoAIzer: A Deep Learning-Based Computational Framework to Characterize Cell Distribution and Gene Mutation in Tumor Microenvironment.

High-throughput functional screening for next-generation cancer immunotherapy using droplet-based microfluidics

Genetic and Phenotypic Profiling of Single Living Circulating Tumor Cells from Patients with Microfluidics

3D Microfluidic model for evaluating immunotherapy efficacy by tracking dendritic cell behaviour toward tumor cells

Drug screening on digital microfluidics for cancer precision medicine

Microfluidics-based patient-derived disease detection tool for deep learning-assisted precision medicine

Immunotherapy discovery on tumor organoid-on-a-chip platforms that recapitulate the tumor microenvironment

Predicting the Tumor Microenvironment Composition and Immunotherapy Response in Non-Small Cell Lung Cancer from Digital Histopathology Images

Drug cytotoxicity and signaling pathway analysis with three-dimensional tumor spheroids in a microwell-based microfluidic chip for drug screening.

Identification and Validation of Efficacy of Immunological Therapy for Lung Cancer From Histopathological Images Based on Deep Learning

Large-Scale Antitumor Screening Based on Heterotypic 3D Tumors Using an Integrated Microfluidic Platform.

In Vivo Dynamic Monitoring of Circulating Melanoma Cells and the Inhibitory Effect of PD-L1 Inhibitor Based on PAFC Equipped with a Deep Learning Framework

A microphysiological assay for studying T-cell chemotaxis, trafficking and tumor killing

An Integrated Microfluidic 3D Tumor System for Parallel and High-Throughput Chemotherapy Evaluation

Evaluation of cancer immunotherapy using mini-tumor chips

Accelerating precision anti-cancer therapy by time-lapse and label-free 3D tumor slice culture platform

Lung tumor microphysiological system with 3D endothelium to evaluate modulators of T-cell migration

Ex Vivo Evaluation of Combination Immunotherapy Using Tumor-Microenvironment-on-Chip.

In Situ Probing of Cell–cell Communications with Surface-Enhanced Raman Scattering (SERS) Nanoprobes and Microfluidic Networks for Screening of Immunotherapeutic Drugs